Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Krebs

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PETSimone Krebs, Darren R Veach, Lukas M Carter, et al.
Med (New York, N.Y.)|September 15, 2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentJasmin Sponagel, Jill K Jones, Cheryl Frankfater, et al.
The Journal of Clinical Investigation|July 3, 2019
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PETSimone Krebs, Darren R Veach, Lukas M Carter, et al.
Med (New York, N.Y.)|September 15, 2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentJasmin Sponagel, Jill K Jones, Cheryl Frankfater, et al.
The Journal of Clinical Investigation|July 3, 2019
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 6